| FSOAX | VMVIX | FSOAX / VMVIX | |
| Total Expense Ratio | 0.96 | 0.19 | 505% |
| Annual Report Gross Expense Ratio | 0.96 | 0.19 | 505% |
| Fund Existence | 30 years | 20 years | - |
| Gain YTD | 23.899 | 10.487 | 228% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.2B | 36.6B | 6% |
| Annual Yield % from dividends | 0.80 | 1.77 | 45% |
| Returns for 1 year | 29.87 | 21.23 | 141% |
| Returns for 3 years | 29.66 | 42.98 | 69% |
| Returns for 5 years | 30.06 | 43.85 | 69% |
| Returns for 10 years | 42.63 | 123.46 | 35% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LRND | 44.39 | 0.72 | +1.65% |
| NYLI U.S. Large Cap R&D Leaders ETF | |||
| ABOT | 37.79 | 0.34 | +0.92% |
| Abacus FCF Innovation Leaders ETF | |||
| FBT | 228.85 | 1.35 | +0.59% |
| First Trust NYSE Arca Biotech ETF | |||
| IFLO | 33.79 | 0.09 | +0.26% |
| VictoryShares Intl Free Csh Flow ETF | |||
| FCSH | 24.16 | 0.04 | +0.15% |
| Federated Hermes Short Duration Corp ETF | |||